These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1189349)

  • 21. Metabolism of normal and pathologic human endometrium.
    Domány S; Székely J; Tóth K
    Acta Physiol Acad Sci Hung; 1967; 32(1):123-9. PubMed ID: 6082979
    [No Abstract]   [Full Text] [Related]  

  • 22. Reduced expression of death-associated protein kinase in human uterine and ovarian carcinoma cells.
    Bai T; Tanaka T; Yukawa K; Maeda M; Umesaki N
    Oncol Rep; 2004 Mar; 11(3):661-5. PubMed ID: 14767518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Electron microscopic and electron radioautographic study of cells in glandular hyperplasia and cancer of the endometrium].
    Buchinskaia LG; Gerasimova TB; Andrianov VM; Polishchuk LZ; Ganina KP
    Tsitol Genet; 1988; 22(5):3-7. PubMed ID: 2465640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NTP Toxicology and Carcinogenesis Studies of C.I. Direct Blue 218 (CAS No. 28407-37-6) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Feb; 430():1-280. PubMed ID: 12616301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microspectrophotometric studies on nuclear DNA activity in endometrium--with particular reference to genesis of endometrial carcinoma.
    Kubo S
    Jikeikai Med J; 1974 Mar; 21(1):25-46. PubMed ID: 4455528
    [No Abstract]   [Full Text] [Related]  

  • 26. [Histopathological aspects of the ovary and endometrium in association with uterine fibromyoma].
    Cadenelli GP; Avanzini L
    Quad Clin Ostet Ginecol; 1967 Jun; 22(6):335-50. PubMed ID: 5614750
    [No Abstract]   [Full Text] [Related]  

  • 27. Current methods in direct imaging of uterine and ovarian tumours.
    Jirous J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1983; 26(1):1-115. PubMed ID: 6587544
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hormonally-active ovarian tumors in 30 years of data (1965-1994)].
    Molnar E; Sloboda L; Fenjvesi A; Zivković S
    Med Pregl; 1999; 52(6-8):241-5. PubMed ID: 10518380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased concentrations of neopterin in plasma, ascites and ovarian cyst fluid in malignant tumours compared with benign ovarian tumours.
    Haeger M; Swahn M; Hahlin M; Horvath G; Bengtsson A
    Anticancer Res; 1996; 16(5B):3189-92. PubMed ID: 8967734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry.
    Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W
    Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Common epithelial tumors of the ovary: proliferating and of low malignant potential.
    Ulbright TM; Roth LM
    Semin Diagn Pathol; 1985 Feb; 2(1):2-15. PubMed ID: 2832916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soluble receptor for urokinase plasminogen activator in both full-length and a cleaved form is present in high concentration in cystic fluid from ovarian cancer.
    Wahlberg K; Høyer-Hansen G; Casslén B
    Cancer Res; 1998 Aug; 58(15):3294-8. PubMed ID: 9699658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibin A levels in cyst fluid from epithelial ovarian tumors.
    Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B
    Acta Obstet Gynecol Scand; 2004 May; 83(5):501-3. PubMed ID: 15059167
    [No Abstract]   [Full Text] [Related]  

  • 34. Calgranulins in cystic fluid and serum from patients with ovarian carcinomas.
    Ott HW; Lindner H; Sarg B; Mueller-Holzner E; Abendstein B; Bergant A; Fessler S; Schwaerzler P; Zeimet A; Marth C; Illmensee K
    Cancer Res; 2003 Nov; 63(21):7507-14. PubMed ID: 14612552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of biochemical markers between benign and malignant ovarian cysts.
    Knight JA; Wu JT; Miya T; Knight DP
    Clin Physiol Biochem; 1986; 4(2):130-5. PubMed ID: 3516514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steroid receptors in normal, hyperplastic and malignant human endometria.
    Vihko R; Jänne O; Kauppila A
    Ann Clin Res; 1980 Oct; 12(5):208-15. PubMed ID: 7015983
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early form of ovarian cancer originating in inclusion cysts. A case report.
    Aoki Y; Kawada N; Tanaka K
    J Reprod Med; 2000 Feb; 45(2):159-61. PubMed ID: 10710752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 years of age and younger.
    Jensen KC; Mariappan MR; Putcha GV; Husain A; Chun N; Ford JM; Schrijver I; Longacre TA
    Am J Surg Pathol; 2008 Jul; 32(7):1029-37. PubMed ID: 18469706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.